INTERMED
-
Cognis develops active ingredients from IMD
Cognis has now exclusively licensed two new active ingredients for weight management and cognitive performance from InterMed Discovery (IMD). Tests on the products Cognis has acquired from IMD are already delivering promising results. The sale…
INTERMED | 28 July 2010
-
Pharma- Food Synergy
By leveraging on the strengths of pharmaceutical research, food manufacturers can know how ingredients interact in the human body at a molecular level.
INTERMED | 01 January 2010
-
InterMed Discovery acquires sustainable source for omega-3 fatty acid
InterMed Discovery (IMD) says it has acquired microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. This microbial source has the potential to produce Omega-3 more sustainably and reliably compared …
INTERMED | 24 August 2009
-
Cognis licenses more active ingredients from InterMed Discovery
Cognis has exclusively licensed two further product candidates from InterMed Discovery (IMD). One is a new functional ingredient, which shows promise in the area of weight management and the other provides beneficial effects for heart health. U…
INTERMED | 20 March 2009
